EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Scalable control of stem cell fate by riboswitch-regulated RNA viral vector without genomic integration

Narae Kim, Yohei Yokobayashi

Molecular Therapy · 2025

DOI: 10.1016/j.ymthe.2025.01.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2025. Verfasst von Narae Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Nucleic Acid Chemistry and Engineering Unit, Okinawa Institute of Science and Technology Graduate University, Onna, Okinawa 904 0495, Japan. Hauptthemen laut MEDLINE: Riboswitch, Genetic Vectors, Mouse Embryonic Stem Cells, RNA, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Okinawa Institute of Science and Technology Graduate University, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transgene expression in stem cells is a powerful means of regulating cellular properties and differentiation into various cell types. However, existing vectors for transgene expression in stem cells suffer from limitations such as the need for genomic integration, the transient nature of gene expression, and the inability to temporally regulate transgene expression, which hinder biomedical and clinical applications. Here we report a new class of RNA virus-based vectors for scalable and integration-free transgene expression in mouse embryonic stem cells (mESCs). The vector is equipped with a small molecule-regulated riboswitch and a drug selection marker that allow temporal regulation of transgene expression and stable maintenance of the vector in proliferating stem cells. We demonstrated the utility of the vector by maintaining the pluripotency of mESCs in a differentiation induction medium by expressing Nanog and inducing myogenic differentiation by triggering Myod1 expression, without altering the mESC genome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RiboswitchGenetic VectorsMouse Embryonic Stem CellsRNA, ViralAnimalsMiceCell DifferentiationMyoD ProteinTransgenesNanog Homeobox ProteinGene Expression Regulation

Stichwörter der Autor:innen

RNA virusaptamersembryonic stem cellsriboswitchesribozymesvesicular stomatitis virus

Substanzen

RiboswitchMyoD ProteinRNA, ViralNanog Homeobox ProteinMyoD1 myogenic differentiation protein

Autor:innen und Institutionen

  • Nucleic Acid Chemistry and Engineering Unit, Okinawa Institute of Science and Technology Graduate University, Onna, Okinawa 904 0495, Japan.
  • Nucleic Acid Chemistry and Engineering Unit, Okinawa Institute of Science and Technology Graduate University, Onna, Okinawa 904 0495, Japan. Electronic address: yohei.yokobayashi@oist.jp.

Förderung

  • Okinawa Institute of Science and Technology Graduate University
  • Japan Society for the Promotion of Science

Zitieren

APA

Kim, N., & Yokobayashi, Y. (2025). Scalable control of stem cell fate by riboswitch-regulated RNA viral vector without genomic integration. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2025.01.005

Vancouver

Kim N, Yokobayashi Y. Scalable control of stem cell fate by riboswitch-regulated RNA viral vector without genomic integration. Molecular Therapy. 2025. doi:10.1016/j.ymthe.2025.01.005

BibTeX
@article{Kim2025,
  author = {Kim, Narae and Yokobayashi, Yohei},
  title = {Scalable control of stem cell fate by riboswitch-regulated RNA viral vector without genomic integration},
  journal = {Molecular Therapy},
  year = {2025},
  doi = {10.1016/j.ymthe.2025.01.005}
}
Kostenlos starten →